Insulin aspart, recombinant Subcutaneous and Vantrela ER
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Vantrela ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: hydrocodone
Brand name: Hysingla ER, Vantrela ER, Zohydro ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Vaprisol
- Insulin aspart, recombinant Subcutaneous-Vaqta
- Insulin aspart, recombinant Subcutaneous-Vaqta Pediatric
- Insulin aspart, recombinant Subcutaneous-Vardenafil
- Insulin aspart, recombinant Subcutaneous-Vardenafil Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Vardenafil ODT
- Vantrela ER-Insulin degludec
- Vantrela ER-Insulin Degludec (U-100) Prefilled Pens
- Vantrela ER-Insulin Degludec (U-100) Vials
- Vantrela ER-Insulin Degludec (U-200) Prefilled Pens
- Vantrela ER-Insulin degludec and liraglutide
- Vantrela ER-Insulin degludec and liraglutide Subcutaneous